CAI vs. TLX
CAI (Caris Life Sciences, Inc) and TLX (Telix Pharmaceuticals Ltd) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. At a 0.09 correlation, their price movements are largely independent.
Performance
CAI vs. TLX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CAI achieves a -42.62% return, which is significantly lower than TLX's 17.09% return.
CAI
- 1D
- -6.30%
- 1M
- -17.17%
- YTD
- -42.62%
- 6M
- -43.17%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
TLX
- 1D
- -4.26%
- 1M
- -21.35%
- YTD
- 17.09%
- 6M
- -9.21%
- 1Y
- -48.32%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CAI vs. TLX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CAI Caris Life Sciences, Inc | -42.62% | -3.64% |
TLX Telix Pharmaceuticals Ltd | 17.09% | -55.84% |
Correlation
The correlation between CAI and TLX is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jun 20, 2025 | 0.09 |
Fundamentals
CAI:
$4.37B
TLX:
$2.97B
CAI:
$0.05
TLX:
$0.12
CAI:
287.88
TLX:
75.65
CAI:
1.10
TLX:
0.09
CAI:
10.78
TLX:
1.48
CAI:
7.37
TLX:
4.77
CAI:
$907.29M
TLX:
$2.00B
CAI:
$482.11M
TLX:
$1.13B
CAI:
$92.24M
TLX:
$153.71M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CAI vs. TLX — Risk / Return Rank
CAI
TLX
CAI vs. TLX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Caris Life Sciences, Inc (CAI) and Telix Pharmaceuticals Ltd (TLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| CAI | TLX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | -0.83 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.75 | -0.53 | -0.22 |
Drawdowns
CAI vs. TLX - Drawdown Comparison
The maximum CAI drawdown since its inception was -62.98%, smaller than the maximum TLX drawdown of -69.37%. Use the drawdown chart below to compare losses from any high point for CAI and TLX.
Loading charts...
Drawdown Indicators
| CAI | TLX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -62.98% | -69.37% | +6.39% |
Max Drawdown (1Y)Largest decline over 1 year | — | -63.33% | — |
Current DrawdownCurrent decline from peak | -60.61% | -58.10% | -2.51% |
Average DrawdownAverage peak-to-trough decline | -31.05% | -36.51% | +5.46% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 43.36% | — |
Volatility
CAI vs. TLX - Volatility Comparison
Loading charts...
Volatility by Period
| CAI | TLX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 12.21% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 40.70% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 62.20% | 58.24% | +3.96% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 62.20% | 57.09% | +5.11% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 62.20% | 57.09% | +5.11% |
Dividends
CAI vs. TLX - Dividend Comparison
Neither CAI nor TLX has paid dividends to shareholders.
Financials
CAI vs. TLX - Financials Comparison
This section allows you to compare key financial metrics between Caris Life Sciences, Inc and Telix Pharmaceuticals Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CAI vs. TLX - Profitability Comparison
CAI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Caris Life Sciences, Inc reported a gross profit of 0.00 and revenue of 216.17M. Therefore, the gross margin over that period was 0.0%.
TLX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Telix Pharmaceuticals Ltd reported a gross profit of 327.42M and revenue of 620.44M. Therefore, the gross margin over that period was 52.8%.
CAI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Caris Life Sciences, Inc reported an operating income of 5.28M and revenue of 216.17M, resulting in an operating margin of 2.4%.
TLX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Telix Pharmaceuticals Ltd reported an operating income of 9.82M and revenue of 620.44M, resulting in an operating margin of 1.6%.
CAI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Caris Life Sciences, Inc reported a net income of -510.00K and revenue of 216.17M, resulting in a net margin of -0.2%.
TLX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Telix Pharmaceuticals Ltd reported a net income of -7.25M and revenue of 620.44M, resulting in a net margin of -1.2%.
Frequently Asked Questions
CAI and TLX have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for CAI and TLX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer